MedTrace Logo

Intravenous Dexamethasone for Ropivacaine Axillary Block

NCT02862327 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2018-01-31

No results posted yet for this study

Summary

Prospective monocentric double-blind controlled randomised trial Aim is to assess prolonged postsurgical analgesia by intravenous dexamethasone versus intravenous placebo, after ultrasound guided axillary brachial plexus block

Conditions

  • Postoperative Pain
  • Anesthesia
  • Forearm Injuries

Interventions

DRUG

intravenous dexamethasone

intravenous injection of dexamethasone

DRUG

intravenous placebo

intravenous injection of placebo

DRUG

perineural ropivacaine

brachial plexus block with perineural injection of Ropivacaine in the axillary fossa

OTHER

ultrasound guidance

ultrasound guidance for brachial plexus block in the axillary fossa

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2017-03-16
Completion
2017-09-16

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02862327 on ClinicalTrials.gov